SeaStar Medical Holding Corporation (ICU)

SeaStar Medical Holding Statistics

Total Valuation

ICU has a market cap or net worth of $23.54 million. The enterprise value is $17.24 million.

Market Cap	23.54M
Enterprise Value	17.24M

Important Dates

The next estimated earnings date is Wednesday, November 12, 2025, after market close.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

ICU has 27.91 million shares outstanding. The number of shares has increased by 249.27% in one year.

Current Share Class	27.91M
Shares Outstanding	27.91M
Shares Change (YoY)	+249.27%
Shares Change (QoQ)	+31.46%
Owned by Insiders (%)	0.96%
Owned by Institutions (%)	2.02%
Float	27.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.98
Forward PS	13.36
PB Ratio	4.38
P/TBV Ratio	7.05
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	22.50
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.52

Current Ratio	1.52
Quick Ratio	1.29
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-400.08

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-156.15%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-443.07%
Revenue Per Employee	$40,316
Profits Per Employee	-$772,158
Employee Count	19
Asset Turnover	0.13
Inventory Turnover	n/a

Taxes

In the past 12 months, ICU has paid $3,000 in taxes.

Income Tax	3,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -82.77% in the last 52 weeks. The beta is -0.97, so ICU's price volatility has been lower than the market average.

Beta (5Y)	-0.97
52-Week Price Change	-82.77%
50-Day Moving Average	0.77
200-Day Moving Average	1.39
Relative Strength Index (RSI)	51.44
Average Volume (20 Days)	1,077,668

Short Selling Information

The latest short interest is 3.13 million, so 11.21% of the outstanding shares have been sold short.

Short Interest	3.13M
Short Previous Month	1.60M
Short % of Shares Out	11.21%
Short % of Float	11.32%
Short Ratio (days to cover)	1.68

Income Statement

In the last 12 months, ICU had revenue of $766,000 and -$14.67 million in losses. Loss per share was -$2.02.

Revenue	766,000
Gross Profit	739,000
Operating Income	-14.80M
Pretax Income	-33.67M
Net Income	-14.67M
EBITDA	n/a
EBIT	-14.80M
Loss Per Share	-$2.02

Balance Sheet

The company has $6.30 million in cash and n/a in debt, giving a net cash position of $6.30 million or $0.23 per share.

Cash & Cash Equivalents	6.30M
Total Debt	n/a
Net Cash	6.30M
Net Cash Per Share	$0.23
Equity (Book Value)	3.34M
Book Value Per Share	0.19
Working Capital	2.61M

Cash Flow

Operating Cash Flow	-15.36M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	96.48%
Operating Margin	-1,932.51%
Pretax Margin	-1,914.88%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ICU does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-249.27%
Shareholder Yield	n/a
Earnings Yield	-62.32%
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 10, 2024. It was a reverse split with a ratio of 1:25.

Last Split Date	Jun 10, 2024
Split Type	Reverse
Split Ratio	1:25

Scores

ICU has an Altman Z-Score of -27.71 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-27.71
Piotroski F-Score	1